Reyon Pharma controlling stake slips to 53.84% after related-party off-market sale
Bitget2026/09/28 08:10- Reyon Pharmaceutical’s controlling shareholder group cut its stake in Ilyon Pharmaceutical to 10,006,691 shares from 10,105,310.
- Ownership fell to 53.84% from 54.37% as related party Yoo Jeong-min sold 98,619 shares off-market on Sept. 18, 2026.
- The sale price was 10,140 per share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The EU questions why a certain exchange continues to operate after being asked to exit
How Strategy keeps STRC near $100 while MSTR stock swings
WTI Crude Oil Drops Over 1.00% Today, Currently at $88.55 per Barrel
Summary of the Bank of Japan's September meeting opinions: Majority of members advocate for continued rate hikes, some call for acceleration.
The summary of the Bank of Japan's September meeting opinions shows that some policymakers believe it is necessary to accelerate interest rate hikes or bring rates closer to the central bank's "target" as soon as possible, increasing the likelihood of further rate hikes.
Crypto prices
More
